Market Overview

TranS1 Inc. Announces Participation at the 2012 Lazard Capital Markets Healthcare Conference


WILMINGTON, N.C., Nov. 1, 2012 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq: TSON) announced today that Ken Reali, President and Chief Executive Officer, and Joe Slattery, Executive Vice President and Chief Financial Officer, are scheduled to present at the 2012 Lazard Capital Markets Healthcare Conference in New York, NY on Wednesday, November 14, 2012 at 11:30 am ET. Institutional investors that wish to request a meeting with TranS1 should contact Lazard Capital Markets.  

About TranS1 Inc.

TranS1 is a medical device company focused on designing, developing and marketing products to treat degenerative conditions of the spine affecting the lower lumbar region. TranS1 currently markets the AxiaLIF® family of products for single and two level lumbar fusion, the VEOTM lateral access and interbody fusion system and the VectreTM posterior fixation system for lumbar fixation supplemental to AxiaLIF fusion. TranS1 was founded in May 2000 and is headquartered in Wilmington, North Carolina. For more information, visit

CONTACT: Investors: TranS1 Inc. Joseph P. Slattery, 910-332-1700 Executive Vice-President and Chief Financial Officer Westwicke Partners Mark Klausner, 443-213-0501
View Comments and Join the Discussion!